115 related articles for article (PubMed ID: 1793331)
1. [Perindopril and chronic heart failure].
Bounhoure JP
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
[TBL] [Abstract][Full Text] [Related]
2. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
[TBL] [Abstract][Full Text] [Related]
4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
[TBL] [Abstract][Full Text] [Related]
5. Effect of perindopril in pacing-induced canine models of acute and chronic heart failure.
Ogilvie RI; Zborowska-Sluis D
Can J Cardiol; 1995 Nov; 11(10):934-40. PubMed ID: 7489534
[TBL] [Abstract][Full Text] [Related]
6. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
Navookarasu NT; Rahman AR; Abdullah I
Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
[TBL] [Abstract][Full Text] [Related]
7. [The long-term administration of perindopril improves the hemodynamic status of rats with heart failure].
Medvedev OS; Zakharova NV
Eksp Klin Farmakol; 1994; 57(6):26-9. PubMed ID: 7756952
[TBL] [Abstract][Full Text] [Related]
8. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
10. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
Sigurdsson A
Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
[TBL] [Abstract][Full Text] [Related]
11. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
12. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
13. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
[TBL] [Abstract][Full Text] [Related]
14. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
15. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
[TBL] [Abstract][Full Text] [Related]
16. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
17. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
West JN; Smith SA; Stallard TJ; Littler WA
J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
[TBL] [Abstract][Full Text] [Related]
18. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
Sami MH
Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
[TBL] [Abstract][Full Text] [Related]
19. Captopril versus perindopril: a double blind study in essential hypertension.
Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
[TBL] [Abstract][Full Text] [Related]
20. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
